Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The hemophilia clinical...
May 05, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight

New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations |...
May 04, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...
May 04, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight

New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight The plasmid DNA...
April 30, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight

New York, USA, April 30, 2026 (GLOBE NEWSWIRE) -- Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs |...
April 30, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Unlock Epidem Insights Instantly with DelveInsight’s DelveEpiAI: An AI-powered Epidemiology Database for Portfolio, Commercial, and Pipeline Decisions

New York, USA, April 30, 2026 (GLOBE NEWSWIRE) -- Unlock Epidem Insights Instantly with DelveInsight’s DelveEpiAI: An AI-powered Epidemiology Database for Portfolio, Commercial, and Pipeline...
April 29, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

New York, USA, April 29, 2026 (GLOBE NEWSWIRE) -- Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight The metagenomics sequencing market is...
April 29, 2026 13:00 ET | Source: DelveInsight Business Research LLP

IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight

New York, USA, April 29, 2026 (GLOBE NEWSWIRE) -- IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight The IgAN market is growing due to...
April 28, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape

New York, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the...
April 28, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight

New York, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight The AAV vector manufacturing...